Q2 Playbook, Cramer Slams Bears on Nvidia, "White Lotus" Surprise 4/1/25
Squawk on the Street
Pharmaceutical Industry's Tariff Request and Legal Concerns for J&J
This chapter explores the pharmaceutical industry's plea to the White House for phased tariffs and its potential effects on research funding. It also delves into current healthcare funding challenges and a legal matter affecting Johnson & Johnson's stock performance.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
